Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Advocates often emphasize the potential for significant therapeutic benefits, principally in conditions where conventional therapies have proven inadequate. However, crucially important to assess the considerable financial burden associated with C